| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/30/2007 | CN1970763A Shortened anti-oncogene p53 capable of increasing sensitivity of human lung cancer cell to antineoplastics |
| 05/30/2007 | CN1970742A Method for united sequential culture of human vaginal epithelial cell by using two kinds of culture medium |
| 05/30/2007 | CN1970080A Method for producing virus vaccine by using suspended Vero cell |
| 05/30/2007 | CN1969836A Ferulic acid and sodium ferulate preparation for inducing stem cell differentiating into nerve stem cell and pharmaceutical application thereof |
| 05/30/2007 | CN1318593C Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318579C Gene engineering method for raising plant useful secondary substance content |
| 05/30/2007 | CN1318578C Domestication method for lotus root group cultivating de-poisoning breeding |
| 05/30/2007 | CN1318577C Medium for protein-free and serum-free cultivation of cells |
| 05/30/2007 | CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/29/2007 | WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 05/29/2007 | US7223908 Plants and seeds of corn variety LH324 |
| 05/29/2007 | US7223905 Plant vitamin E biosynthetic enzymes |
| 05/29/2007 | US7223904 Plant gene sequences II |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223840 Antimicrobial peptide |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 05/29/2007 | US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/29/2007 | US7223740 isolated host cell; treatment of arterial diseases, comprising intramuscularly administering a vector |
| 05/29/2007 | US7223600 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 05/29/2007 | US7223599 Immortalization of human post-mitotic cells |
| 05/29/2007 | US7223598 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/29/2007 | US7223596 Immortalized hemangiosarcoma cell line comprising expression characteristics and growth factor and cytokine expression profiles typical of nonmalignant activated endothelial cells for use as model in identifying modulators from controlling angiogenesis |
| 05/29/2007 | US7223595 Use of purified Streptomyces griseus trypsin for production of a biomass of cells and viral propagation |
| 05/29/2007 | US7223594 Immunogens; replication-defective; antibodies; host cells; kits |
| 05/29/2007 | US7223589 Bacterium for the production of 2′-deoxyribonucleoside |
| 05/29/2007 | US7223586 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 05/29/2007 | US7223580 N-acetylglucosamine transferase, nucleic acid encoding the same and use thereof in diagnosing cancer and/or tumor |
| 05/29/2007 | US7223566 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 05/29/2007 | US7223565 for drug screening interleukins; expression in bacteria, yeast, plant, insect, and animal cells; genetic engineering |
| 05/29/2007 | US7223564 Four-helical bundle protein zsig81 |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223562 Nucleic acid and amino acid sequences of FP-1 protein expressed in follicular papilla of hair follicle; antibodies; transformation, genetic engineering |
| 05/29/2007 | US7223558 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 05/29/2007 | US7223557 Polynucleotide encoding a TRP channel family member, TRP-PLIK2 |
| 05/29/2007 | US7223556 Targeted proteolysis by recruitment to ubiquitin protein ligases |
| 05/29/2007 | US7223551 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants |
| 05/29/2007 | US7223549 Compositions for identification and isolation of stem cells |
| 05/29/2007 | US7223407 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying |
| 05/29/2007 | US7223394 Human antibodies that bind human TNFα |
| 05/29/2007 | US7223393 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents |
| 05/29/2007 | US7223391 Administering subject's modified blood on consecutive days; blood is modified extracorporeally by exposure from 2 to 5 minutes to a combination of stressors; treating ischemic stress, atherosclerosis and rheumatoid arthritis |
| 05/29/2007 | US7223389 Compositions and methods for treatment of cancer |
| 05/29/2007 | US7223388 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 05/29/2007 | CA2389990C Compositions and methods for modulation of plant cell division |
| 05/29/2007 | CA2341685C Secreted renilla luciferase |
| 05/29/2007 | CA2262476C Viral vectors and their uses |
| 05/29/2007 | CA2236998C Tissue-specific and target rna-specific ribozymes |
| 05/29/2007 | CA2154368C Therapeutic applications of chimeric organogenesis |
| 05/29/2007 | CA2082042C Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 05/24/2007 | WO2007059501A2 Extracellular matrix components for expansion or differentiation of hepatic progenitors |
| 05/24/2007 | WO2007059470A2 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 05/24/2007 | WO2007059253A2 Progenitor endothelial cell capturing with a drug eluting implantable medical device |
| 05/24/2007 | WO2007059120A2 Allelic form of the hmga2 gene predisposing women to the formation of leiomyomas |
| 05/24/2007 | WO2007059082A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 05/24/2007 | WO2007059007A2 Markers of definitive endoderm |
| 05/24/2007 | WO2007058987A1 Methods of identifying compounds that inhibit notch cleavage |
| 05/24/2007 | WO2007058878A2 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 05/24/2007 | WO2007058671A1 Novel uses of cells with prenatal patterns of gene expression |
| 05/24/2007 | WO2007058497A1 Method for inducing the differentiation of human myelogenous leukemia cells into megakaryocytes or thrombocytes |
| 05/24/2007 | WO2007058404A1 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
| 05/24/2007 | WO2007058401A1 Composition comprising okadaic acid for undifferentiated proliferation of embryonic stem cells |
| 05/24/2007 | WO2007058381A1 Novel highly functional enzyme having modified substrate-specificity |
| 05/24/2007 | WO2007058308A1 Aqueous solution for cell preservation |
| 05/24/2007 | WO2007058267A1 Novel protein and gene encoding the protein |
| 05/24/2007 | WO2007058235A1 Fusion protein and use thereof for pharmaceutical purposes |
| 05/24/2007 | WO2007058140A1 Luciferase gene optimized for use in imaging of intracellular luminescence |
| 05/24/2007 | WO2007058105A1 Method for producing pancreas from es cell |
| 05/24/2007 | WO2007058021A1 Animal model and method for producing the same |
| 05/24/2007 | WO2007057853A2 Immortal pluripotent stem cell line, cell lines derived therefrom, methods of preparing thereof and their uses |
| 05/24/2007 | WO2007057670A1 Nidogen/snep-iike molecule |
| 05/24/2007 | WO2007057402A1 Emp4 gene |
| 05/24/2007 | WO2007056994A2 Method for the production of permanent human cell lineages |
| 05/24/2007 | WO2007056867A1 Modified pore-forming protein toxins and use thereof |
| 05/24/2007 | WO2007056858A1 Anti-alpha2 integrin antibodies and their uses |
| 05/24/2007 | WO2007056854A1 Method of expanding double negative t cells |
| 05/24/2007 | WO2007039662A3 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines |
| 05/24/2007 | WO2007038933A3 A method for producing cells with efficient engraftment within the heart |
| 05/24/2007 | WO2007033221A3 Methods and compositions for inhibition of immune responses |
| 05/24/2007 | WO2007028101A9 Osteogenic and anti-adiogenic oxysterols |
| 05/24/2007 | WO2007028041A3 Loading of cells with antigens by electroporation |
| 05/24/2007 | WO2007020449A3 Implantable cartilaginous tissue repair device |
| 05/24/2007 | WO2007009013A3 Methods and compositions related to a braf mutation and microsatellite stability |
| 05/24/2007 | WO2007005611A3 Progenitor cells and uses thereof |
| 05/24/2007 | WO2006102652A3 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 05/24/2007 | WO2006039582A3 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 05/24/2007 | WO2006038211A3 Disease treatment via developing non-syngeneic graft transplantation |
| 05/24/2007 | WO2005112622A3 Regulation of transcription with a cis-acting ribozyme |
| 05/24/2007 | WO2005016952A3 Polyvalent immunogen |
| 05/24/2007 | US20070118934 Chimeric toxin receptor proteins and chimeric toxin receptor proteins for treatment and prevention of anthrax |
| 05/24/2007 | US20070118933 Seed-specific gene promoters and uses thereof |
| 05/24/2007 | US20070118930 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 05/24/2007 | US20070118929 Delta-9 elongases and their use in making polyunsaturated fatty acids |
| 05/24/2007 | US20070118928 Transgenic plant and method for altering oil and protein plant content |
| 05/24/2007 | US20070118927 Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass (lolium) and fescue (festuca) |
| 05/24/2007 | US20070118926 Engineering broad spectrum virus disease resistance in plants based on the regulation of expression of the RNA dependant RNA polymerase 6 gene |